Debate Session: is biomarker-based cancer treatment cost-effective or a financial burden (focus: Prostate Cancer)?
Debate Session: is biomarker-based cancer treatment cost-effective or a financial burden (focus: Prostate Cancer)?
Expert
Aristotelis Bamias
Expert
Bertrand Tombal
Expert
Milos Grujic
Custom